HIF1A and chronic obstructive pulmonary disease: Some of the mechanisms by which M. pneumoniae could enhance the negative effects of tobacco products in COPD patients is by increasing oxidative stress [31], inflammation status and hypoxia-related factors, such as HIF-1α [32].